Literature DB >> 20123111

Cytokine induced expression of programmed death ligands in human neutrophils.

Paul E Bankey1, Sanjib Banerjee, Andrea Zucchiatti, Mita De, Rami W Sleem, Chuen-Fu L Lin, Carol L Miller-Graziano, Asit K De.   

Abstract

Recent evidence indicates that human neutrophils can serve as non-professional antigen presenting cells (APC). Although expression of MHC class II and co-stimulatory molecules on human neutrophils is limited, these molecules can be significantly induced following in vitro exposure to the cytokines IFNgamma and GM-CSF. Since professional APCs such as dendritic cells express both co-stimulatory and co-inhibitory molecules for activation and regulation of adaptive immunity, we determined whether cytokines induce increased expression of specific co-signaling molecules on human neutrophils. We report here that circulating human neutrophils express co-inhibitory molecules such as immunoglobulin-like transcript (ILT) 4 and 5, and also comparatively low and highly variable levels of ILT2 and ILT3, but the expression of these ILTs was not significantly changed by cytokine treatment. In contrast, we demonstrate for the first time that human peripheral blood neutrophils, although do not express the co-inhibitory molecule, programmed death ligand (PD-L) 1 on their surface, can express this molecule at moderate levels following cytokine exposure. Although moderate PD-L1 levels on healthy volunteers' neutrophils were not inhibitory to T cells, our findings do not exclude a possible robust increase in neutrophil PD-L1 expression in pathological conditions with immunosuppressive functions. These results suggest a possible immunoregulatory role for human neutrophils in adaptive immunity. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123111      PMCID: PMC2849642          DOI: 10.1016/j.imlet.2010.01.006

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  39 in total

1.  Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells.

Authors:  C Iking-Konert; S Vogt; M Radsak; C Wagner; G M Hänsch; K Andrassy
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

2.  CD9 and HLA-DR expression by crevicular epithelial cells and polymorphonuclear neutrophils in periodontal disease.

Authors:  C Bisson-Boutelliez; N Miller; D Demarch; M C Bene
Journal:  J Clin Periodontol       Date:  2001-07       Impact factor: 8.728

3.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

4.  Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Authors:  Tyler J Curiel; Shuang Wei; Haidong Dong; Xavier Alvarez; Pui Cheng; Peter Mottram; Roman Krzysiek; Keith L Knutson; Ben Daniel; Maria Carla Zimmermann; Odile David; Matthew Burow; Alan Gordon; Nina Dhurandhar; Leann Myers; Ruth Berggren; Akseli Hemminki; Ronald D Alvarez; Dominique Emilie; David T Curiel; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

5.  Inhibition of p38 mitogen activated protein kinase increases lipopolysaccharide induced inhibition of apoptosis in neutrophils by activating extracellular signal-regulated kinase.

Authors:  K Sheth; J Friel; B Nolan; P Bankey
Journal:  Surgery       Date:  2001-08       Impact factor: 3.982

6.  Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo.

Authors:  W Reinisch; C Lichtenberger; G Steger; W Tillinger; O Scheiner; A Gangl; D Maurer; M Willheim
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

Review 7.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

8.  Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7.

Authors:  Nicodemus Tedla; Christianne Bandeira-Melo; Paolo Tassinari; David E Sloane; Mary Samplaski; David Cosman; Luis Borges; Peter F Weller; Jonathan P Arm
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-14       Impact factor: 11.205

9.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

Authors:  Xingluo Liu; Jian Xin Gao; Jing Wen; Lijie Yin; Ou Li; Tao Zuo; Thomas F Gajewski; Yang-Xin Fu; Pan Zheng; Yang Liu
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  14 in total

1.  Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559).

Authors:  Richard S Hotchkiss; Elizabeth Colston; Sachin Yende; Derek C Angus; Lyle L Moldawer; Elliott D Crouser; Greg S Martin; Craig M Coopersmith; Scott Brakenridge; Florian B Mayr; Pauline K Park; June Ye; Ian M Catlett; Ihab G Girgis; Dennis M Grasela
Journal:  Crit Care Med       Date:  2019-05       Impact factor: 7.598

2.  Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-L-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells.

Authors:  Daria Bortolotti; Joel LeMaoult; Claudio Trapella; Dario Di Luca; Edgardo D Carosella; Roberta Rizzo
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

3.  Trauma-associated human neutrophil alterations revealed by comparative proteomics profiling.

Authors:  Jian-Ying Zhou; Ravi K Krovvidi; Yuqian Gao; Hong Gao; Brianne O Petritis; Asit K De; Carol L Miller-Graziano; Paul E Bankey; Vladislav A Petyuk; Carrie D Nicora; Therese R Clauss; Ronald J Moore; Tujin Shi; Joseph N Brown; Amit Kaushal; Wenzhong Xiao; Ronald W Davis; Ronald V Maier; Ronald G Tompkins; Wei-Jun Qian; David G Camp; Richard D Smith
Journal:  Proteomics Clin Appl       Date:  2013-05-22       Impact factor: 3.494

4.  IFN-γ-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1.

Authors:  Stan de Kleijn; Jeroen D Langereis; Jenneke Leentjens; Matthijs Kox; Mihai G Netea; Leo Koenderman; Gerben Ferwerda; Peter Pickkers; Peter W M Hermans
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

5.  Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers.

Authors:  Kwang-Yu Chang; Nai-Jung Chiang; Shang-Yin Wu; Chia-Jui Yen; Shang-Hung Chen; Yu-Min Yeh; Chien-Feng Li; Xiaoxing Feng; Katherine Wu; Amanda Johnston; John S Bomalaski; Bor-Wen Wu; Jianjun Gao; Sumit K Subudhi; Ahmed O Kaseb; Jorge M Blando; Shalini S Yadav; Peter W Szlosarek; Li-Tzong Chen
Journal:  Oncoimmunology       Date:  2021-07-12       Impact factor: 8.110

6.  Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis.

Authors:  Finlay W McNab; Matthew P R Berry; Christine M Graham; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Robert J Wilkinson; Onn M Kon; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Eur J Immunol       Date:  2011-05-27       Impact factor: 5.532

7.  Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy.

Authors:  Massimo Conese; Stefano Castellani; Silvia Lepore; Orazio Palumbo; Antonio Manca; Teresa Santostasi; Angela Maria Polizzi; Massimiliano Copetti; Sante Di Gioia; Valeria Casavola; Lorenzo Guerra; Anna Diana; Pasqualina Montemurro; Maria Addolorata Mariggiò; Crescenzio Gallo; Angela Bruna Maffione; Massimo Carella
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

8.  Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma.

Authors:  Gaixia He; Henghui Zhang; Jinxue Zhou; Beibei Wang; Yanhui Chen; Yaxian Kong; Xingwang Xie; Xueyan Wang; Ran Fei; Lai Wei; Hongsong Chen; Hui Zeng
Journal:  J Exp Clin Cancer Res       Date:  2015-11-18

9.  Programmed death ligand 1 expression in esophageal cancer following definitive chemoradiotherapy: Prognostic significance and association with inflammatory biomarkers.

Authors:  Yating Tang; Guang Li; Shan Wu; Lingrong Tang; Ning Zhang; Jinzhao Liu; Shuo Zhang; Lei Yao
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

Review 10.  Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance.

Authors:  Charita Furumaya; Paula Martinez-Sanz; Panagiota Bouti; Taco W Kuijpers; Hanke L Matlung
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.